This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
1 Smart Insulin Pen Cap System Shows Sustained Glycemic Improvement Over 12 Months | ADA 2025 / Orawan - stock.adobe.com The system, called the Bigfoot Unity Diabetes Management System, integrates with the FreeStyle Libre 2 sensor and supports commonly used insulin pens to simplify diabetes care. at baseline to 8.0±1.2%
A collaborative and patient-centered approach is crucial in improving polypharmacy outcomes, according to a study published in Intelligent Hospital. Intelligent Hospital. Published online June 29, 2025:100006. Accessed July 18, 2025. The dangers of polypharmacy and the case for deprescribing in older adults.
Pharmacists can also provide diabetes management as an embedded member of clinic or hospital locations. July 15, 2025. Accessed July 21, 2025. Accessed July 21, 2025. The FDA approved insulin aspart-xjhz (Kirsty) 100 units/mL as the first and only interchangeable biosimilar to insulin aspart (NovoLog). News release.
Recent Videos Related Content Q&A: How Advancements in GLP-1s, CGM Impact Insulin Management Brian Nowosielski ; Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES July 15th 2025 Article Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discusses how diabetes advancements like GLP-1s and CGM have impacted the management of insulin.
Most of the students observed burnout among community chain pharmacists (90%), then community independent (69%), and hospital and health system (65%). April 24, 2025:100049. June 16, 2025. Accessed July 9, 2025. Accessed July 9, 2025. Etter N, Gerhards K. University of Wisconsin School of Pharmacy.
Recent Videos Related Content Q&A: Pharmacists Play Essential Role in Insulin Therapy Success Killian Meara ; Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM July 15th 2025 Article Jennifer Clements, PharmD, FCCP, FADCES, BCPS, CDCES, BCACP, BC-ADM, discusses how pharmacists can help patients manage insulin.
The Evolving Landscape of Insulin Delivery in Diabetes Management Brian Nowosielski ; Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES July 17th 2025 Podcast Amid increased advancements in diabetes management, Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, discussed how these developments are currently impacting the delivery of insulin.
READ MORE: Insulin Advancements Led to Safer Surgeries, Shorter Hospital Stays Drug Topics : How has the administration of insulin management been impacted by medical advancements in things like CGM and GLP-1 medications? Diana Isaacs: It's really interesting. Subscribe Now!
Additional advantages include fewer emergency visits, hospitalizations, medication adherence, and associated cost savings. The study also sought to determine the rate of achieving goal A1c, mean A1c reduction, and rate of hospitalization and emergency department visits. 2025 May 6:102413. million people, or 11.6% References 1.
2 Pharmacists can play a large role in the management of IBD, especially because medication nonadherence is common, leading to increased flares, hospitalizations, and complications. Additionally, pharmacists can make sure that patients have updated immunizations, especially for patients who are on immunosuppressive therapy.
In a session at the Pharmacy Quality Alliance Annual Meeting 2025, presenters stated that approximately 68% of patients have at least 1 unmet SDOH. The Mount Sinai Hospital. June 18, 2025. Accessed June 18, 2025. Why Digital Innovation Will Transform the Future of Smart Pharmacy | NCPDP 2025. May 15, 2025.
In a review earlier in 2025, it was estimated that adolescent obesity affects 21% of patients aged 12 to 18 years. January 30, 2025. Accessed July 21, 2025. GLP-1 Use Increased Significantly Among Pediatric Patients With T2D in Past 5 Years | ADA 2025. June 25, 2025. Accessed July 21, 2025. Drug Topics.
That was the question on the minds of a lot of health care professionals, public policy leaders, public health officials, and select politicians going into the first meeting of the new Advisory Committee on Immunization Practices (ACIP) in June 2025.
Parental vaccine hesitancy, fueled by misinformation and logistical barriers, contributes to lower immunization rates and increased exemption rates. Collaborative programs between public health departments, schools, and pharmacies aim to streamline vaccine access and improve immunization coverage.
Prior to October 2024, the Advisory Committee on Immunization Practices (ACIP) recommended use of a PCV only for all adults aged 65 years and older, including those aged 19 to 64 years with risk conditions for pneumococcal disease.
1 Population cohorts included adults ages 65 or older enrolled in Medicare and adults ages 19 to 64 years enrolled in Medicaid and deemed eligible for pneumococcal vaccination based on Advisory Committee on Immunization Practices recommendations. Accessed July 23, 2025. Accessed July 23, 2025. Last Updated October 26, 2024.
1 The 2024-2025 updated COVID-19 vaccine containing the Omicron JN.1 Image Credit: Jesse B/peopleimages.com - stock.adobe.com In the study, eligible patients from Denmark who previously had 3 or more COVID-19 doses received the 2024-2025 JN.1 The study took place from May 1, 2024, to March 31, 2025. 1 booster vaccination. .
Experts Debate Diabetes Care in Community Pharmacy vs Health Systems Despite evidence of improved diabetes outcomes, all pharmacy settings are capable of having a significant impact on diabetes care, according to a presentation at the American Pharmacists Association (APhA) 2025 Annual Meeting and Exposition.
Investigators from Harvard Medical School and Brigham and Women’s Hospital conducted a study to compare the risk of cardiovascular events after starting treatment with individual sulfonylureas or DPP4 inhibitors. had an ischemic stroke, 3% had a heart failure hospitalization, and 0.4% of patients experienced a MACE-4: 2.2%
Abigail Beaney July 23, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The new legislation will reduce the time it takes for patients to receive these therapies from months to days. Go deeper with GlobalData Reports China Contract Manufacturing Market Outlook - Trends, Ambitions, Ke.
Shingles, or herpes zoster, affects about 1 in 3 people in the United States during their lifetime, with risk increasing with age or a weakened immune system. Hospitalization occurs in 1% to 4% of cases, mostly involving immunocompromised individuals. July 17, 2025. Accessed July 18, 2025. Accessed July 18, 2025.
The 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois, showcased significant advances across a range of malignancies, with novel agents, biomarker-driven strategies, and long-term outcomes data offering new insights into cancer treatment with implications for pharmacy practice.
SHOW MORE Administering influenza, COVID-19, and RSV immunizations at the same time may improve vaccine uptake. Pediatric vaccination laws vary, but pharmacists play a crucial role in educating families about vaccines like MMR, Tdap, and HPV. Before autumn approaches, start thinking about respiratory vaccines.
Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting. Soefje, PharmD, MBA, BCOP, FCCP, FHOPA Scott Soefje, PharmD, MBA, BCOP, shares insights about the evolving role of pharmacists at the 2025 OPC meeting.
Finerenone and the Future of Diabetes-Related Kidney Care Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Subscribe Now!
June 13, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook GSK’s vaccine leverages GMMA technology. The technology utilises outer membrane vesicles (OMVs) to deliver antigens, often eliminating the need for adjuvants while triggering the immune response. Give your business an edge with our leading industry insights.
1 “Eligible outcomes included changes in health-related quality of life, medication adherence, hospitalization rates, inhalation techniques, or disease-related knowledge." " Finally, pharmacist-led interventions were all conducted in community pharmacies, outpatient clinics, or hospital settings. 2025; [link] 2.
July 30, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook MP1032 is intended for treating Duchenne muscular dystrophy. “MP1032’s unique mechanism — modulating mitochondrial ROS in overactive immune cells — could transform long-term DMD management by slashing corticosteroid doses and side effects.
Accessed June 10, 2025. Accessed June 10, 2025. Accessed June 10, 2025. Accessed June 10, 2025. Healthy People 2030. link] Flu vaccination coverage, United States, 2023-24 influenza season. September 20, 2024. link] FluVaxView. link] Brenan M. Nurses retain top ethics rating in U.S., but below 2020 high. January 10, 2023.
McKesson ideaShare 2025 brought thousands of independent pharmacists, pharmacy owners, technicians, and industry leaders together in Nashville, Tennessee, shining a spotlight on innovation and advocacy in community pharmacy. SHOW MORE Dave’s Pharmacy in Alliance, Nebraska, was named the Pharmacy of the Year for cutting-edge patient care.
Accessed July 23, 2025. January 14, 2025. Accessed July 23, 2025. Accessed July 23, 2025. link] To Prohibit a Pharmacy Benefits Manager from Obtaining Certain Pharmacy Permits (AK HB1150); 2025. link] To Prohibit a Pharmacy Benefits Manager from Obtaining Certain Pharmacy Permits (AK HB1150); 2025.
The injection's room-temperature stability and compatibility with automated dispensing cabinets facilitate integration into hospital workflows. The study authors noted that sepsis is also a leading cause of death and hospitalization that often requires antibiotic administration.
At McKesson ideaShare 2025, pharmacy leaders spotlighted the growing role of pharmacists in expanding clinical services, including telehealth, contraception prescribing, naloxone access, and point-of-care testing (POCT). SHOW MORE Pharmacy-based clinical services demonstrate both public health impact and financial sustainability.
Pharmacy Times : Can you share your experience at OPC 2025 and the significance of these meetings for pharmacists? Related Videos Related Content Advertisement June 20th 2025 Unicorns Don’t Exist: Rethinking the Generalist Model in Oncology Pharmacy Kelley D. Sessions : Oncology Pharmacists Connect—this is the third year, right?
In an interview with Pharmacy Times® , Gabe Hinojosa, PharmD, BCOP, clinical pharmacy specialist oncology/hematology at UT Southwestern, discussed the evolving treatment landscape for multiple myeloma (MM) and presented data from the 2025 American Society of Clinical Oncology Annual Meeting (ASCO).
Image Credit: WindyNight - stock.adobe.com "Our findings showed that adolescents who received this combination therapy were able to improve many symptoms typically associated with insulin-managed type one diabetes,” Farid Mahmud, MD, FRCPC, physician at The Hospital for Sick Children, said in a news release. June 17, 2025.
2 In April 2025, the FDA announced its plan to phase out the animal testing requirements and require new approach methodologies (NAMs) in early research to streamline which treatments will be safe and effective in humans, reduce drug development costs and timelines, and reduce testing in animals.
Furthermore, delays in medication access can exacerbate chronic conditions, such as diabetes, hypertension, and asthma, leading to increased hospitalization rates. The lack of access to immunization services may lead to lower vaccination rates and vulnerabilities to infectious diseases in these communities.
John’s University – College of Pharmacy and Health Sciences and practices as an infectious diseases pharmacist at NYC Health + Hospitals/Elmhurst in Elmhurst, New York. Accessed March 2, 2025. Accessed March 5, 2025. Accessed March 5, 2025. Clinical and Laboratory Standards Institute; 2025. Cephalexin. Lexi-Drugs.
Accessed June 4, 2025. Accessed June 4, 2025. Updated February 15, 2025. Accessed June 4, 2025. Accessed June 4, 2025. Accessed June 4, 2025. Accessed June 4, 2025. Accessed June 4, 2025. Accessed June 4, 2025. REFERENCES Rivaroxaban. MedlinePlus. Updated April 15, 2023. link] Edoxaban.
Wick, MBA, RPh, FASCP Key Takeaways Pharmacists can address SDOH by providing patient-centered care, promoting immunizations, and offering point-of-care testing to improve health outcomes. Offering and promoting immunizations and point-of-care testing are 2 proven ways to address SDOH.
A retrospective study presented at the American Society of Health-System Pharmacists 2025 Pharmacy Futures meeting has revealed significant variability in asthma treatment regimens following initial diagnosis, with many patients not receiving care aligned with the Global Initiative for Asthma (GINA) recommendations.
Accessed June 17, 2025. Updated February 2025. Accessed June 17, 2025. Related Videos Related Content Advertisement July 21st 2025 Under the Weather: Unpacking the Impact of the 2024-2025 Influenza Season Tori L. Health Sci Rep. 2025;8(4):e70747. doi:10.1002/hsr2.70747 Continuous glucose monitors. link] Miller EM.
These conclusions were presented as part of an abstract from the open-label, phase 3 CheckMate 816 trial (NCT02998528) at the 2025 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois, and subsequently published in the Journal of Clinical Oncology.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content